The Role of Regulation - What Does European Centralized Switching Mean and What Are the Experiences

• In: 4J - Switching from prescription to non-prescription status: Challenges and opportunities on Monday, 8 October 2012, 12:15-13:45
• At: Amsterdam (the Netherlands) (2012)
• Type: Presentation
• By: SVARCAITE, Jurate (PGEU, Professional Affairs, Brussels, Belgium)
• Abstract:

  The market for self-medication continues to evolve, with increasing layers of complexity, and despite the economic crises remains a profitable share of overall pharma market. Innovation in the switching process and categories that are considered for switching, greater promotion of self-medication are among the factors contributing to the growth.

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login